Edelman-Klapper, H.; Rabinowitz, K.M.; Zittan, E.; Bar-Gil Shitrit, A.; Goren, I.; Avni-Biron, I.; Ollech, J.E.; Lichtenstein, L.; Banai-Eran, H.; Yanai, H.;
et al. Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines 2023, 11, 1263.
https://doi.org/10.3390/vaccines11071263
AMA Style
Edelman-Klapper H, Rabinowitz KM, Zittan E, Bar-Gil Shitrit A, Goren I, Avni-Biron I, Ollech JE, Lichtenstein L, Banai-Eran H, Yanai H,
et al. Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines. 2023; 11(7):1263.
https://doi.org/10.3390/vaccines11071263
Chicago/Turabian Style
Edelman-Klapper, Hadar, Keren Masha Rabinowitz, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai,
and et al. 2023. "Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases" Vaccines 11, no. 7: 1263.
https://doi.org/10.3390/vaccines11071263
APA Style
Edelman-Klapper, H., Rabinowitz, K. M., Zittan, E., Bar-Gil Shitrit, A., Goren, I., Avni-Biron, I., Ollech, J. E., Lichtenstein, L., Banai-Eran, H., Yanai, H., Snir, Y., Pauker, M. H., Friedenberg, A., Levy-Barda, A., Broitman, Y., Ben Zvi, H., Perets, T. -T., Eliakim, R., Barkan, R.,
... Dotan, I., on behalf of the REsponses to COVid-19 vaccinE IsRaeli IBD group [RECOVERI].
(2023). Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines, 11(7), 1263.
https://doi.org/10.3390/vaccines11071263
